Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atacicept in Systemic Lupus Erythematosus (APRIL-SLE)
NCT00624338Phase 3Completed
- Sponsor
- EMD Serono
- Start
- Jan 2008
- Primary completion
- Apr 2012
- Countries
- 29
01
Overview
A Phase 3 trial of atacicept in systemic lupus erythematosus (SLE), sponsored by EMD Serono. Started Jan 2008; status: completed.
02
Drugs
atacicept
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT00624338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00624338.